seaweed; biochemical composition; biorefinery; Gracilaria; Lesina Lagoon; mangrove-derived actinomycetes; genome mining; halogenase; enduracidin; ansamycin; deep ocean water; obesity; Monascus; monascin; ankaflavin; Streptomyces xiamenensis; ribosome engineering; benzopyran; anti-fibrosis; peptaibols; trichorzianines; Trichoderma atroviride; Axinella polypoides; Axinella verrucosa; chitosan; alginate; fucoidan; bone tissue engineering; biomaterials; marine organism; halisulfate 3; suvanine; hepatitis C virus; NS3 helicase; dengue virus; rubromycin; hyaluronidase inhibitor; marine actinomycetes; Streptomyces; 2-amino-3-hydroxycyclopent-2-enone; Trididemnum orbiculatum; Solwaraspora; methicillin-resistant Staphylococcus aureus; structural and functional characterization of marine drug; marine biotechnology; bioactive compounds and bioproducts; drug discovery and development; biosilica; polyphosphate; multipotent stromal cells; mesenchymal stem cells; alkaline phosphatase; 3D cell/tissue printing; distraction osteogenesis; optimization; lipid production; Scenedesmus sp.; response surface methodology; biodiesel; lipid extraction; wet microalga; biofuel; ethanol; Picochlorum sp.; real-time PCR; large subunit ribosomal RNA (LSU rRNA) gene; dinoflagellate monitoring; biotoxin production; ultrafiltration; proteolysis; ACE inhibitory peptides; cuttlefish byproducts; peptide identification; HPLC-ESI-MS; genomics; evolution; biotechnology; arthropods; crustaceans; decapod; shrimp; CS5931; anti-angiogenesis; zebrafish; HUVECs; VEGF and MMPs; microalgae; outdoor; Nannochloropsis; large-scale; lipids; fatty acids; nitrogen manipulation; seasonal changes; biofuels; high value products; Amphibalanus amphitrite; antifouling; natural product antifoulants; alkylpyridinium polymers; Haliclona (Rhizoniera) sarai; barnacle; settlement assay; toxicity assay; swimming inhibition assay; aldehydes; molecular targets; sea urchin; teratogenesis; deep-sea sediment; metagenomic clone; indole alkaloids; metagenetriindole A; metagenebiindole A; cytotoxicity; sponge; rare actinomycete; Amycolatopsis; benzofuran; cyclopiazonic acid; oxidative stress; DHA; fat-1; neural progenitor cells; dimethyl ether; supercritical CO₂; fucoxanthin; wet extraction; giant grouper; inbreeding; mitochondria; microsatellite; anticoagulant effect; antiplatelet activity; brown algae; Dictyota menstrualis; diterpenes; aragonite; conotoxins; neurodegeneration; neuroinflammation; Aβ peptide; tau hyperphosphorylation; protein kinases; receptors; voltage-dependent ion channels; cyclooxygenases; Plakortis halichondroides; plakortide E; protease inhibitor; slowly-binding reversible inhibitor; cathepsin; rhodesain; sea cucumber viscera; saponins; Holothuria lessoni; bioactive compounds; MALDI; mass spectrometry; ESI; HPCPC; triterpene glycosides; structure elucidation; marine invertebrate; Echinodermata; holothurian; PKS I; PKS II; NRPS; Red Sea; sponges; actinomycetes; bioactivity; anti-angiogenesis; catunaregin; VEGF; zebrafish; HUVECs; Raman microspectroscopy; in situ detection; antibiotics; secondary metabolites; actinomycetes; seaweed; macroalgae; genetic engineering; GMO; gene flow; bio-safety; marine algae; transgenic algae; expression system; 10-acetylirciformonin B; apoptosis; hexokinase; mitochondria; reactive oxygen species (ROS); topoisomerase; clavatustides; stress-driven discovery; hydrothermal vent; anti-cancer; marine oleaginous diatom; Fistulifera solaris; lipid synthesis; eicosapentaenoic acid (EPA); PC-based acyl-editing; quorum sensing; quorum quenching; marine; AHL-degrading activity; antivirulence therapy; antibiotic resistance; sulfated polysaccharide; fucoidan; diabetic nephropathy; behavior-based screen; zebrafish; PTZ; c-fos; Conus bandanus; cone snail venom; mass spectrometry; BnIIID; bromotryptophan; γ-carboxy glutamate; post-translational modifications; chromomycin A₂; chromomycin A₃; actinomycetes; TRAIL; Wnt; marine bioactive compounds; metagenomics; synthetic biology; biocatalyst discovery; metaproteomic; dereplication; omic approaches; Porifera; biochemical composition; Amphimedon queenslandica; amino acid analysis; FAME analysis; spongin; bis(2,3-dibromo-4,5-dihydroxybenzyl) ether; Botrytis cinerea; antifungal; DNA interaction; shark cartilage; type II collagens; denaturation temperature; FTIR; SEM; antioxidant activity; cell culture; echinochrome; gene expression; MALDI TOF MS; ESI MS; marine biotechnology; naphthoquinone pigments; pigment differentiation; proliferation; sea urchin; signal sequence; endoplasmic reticulum; diatom oleosome-associated protein; Fistulifera solaris JPCC DA0580; marine oleaginous diatom; marine natural products; aquaculture; microbial symbionts; marine invertebrates; pharmaceuticals; adiponectin; adipocyte; α-pyrone; γ-pyrone; Nocardiopsis; marine sponges; porifera; marine natural products; anticancer; sponge-associated bacteria; drug; bioactive compounds; mollusks; symbiotic bacteria; fatty acids; phospholipids; metagenome; siderophore; avaroferrin; biosynthesis; heterologous expression; (−)-elatol; Laurencia dendroidea; Trypanosoma cruzi; Chagas’ disease; reactive oxygen species; Salicornia herbacea; osteoporosis; adipogenesis; osteoblastogenesis; xenobiotic; nuclear receptor; bioassay; marine; bioactive; invertebrate

Advances and New Perspectives in Marine Biotechnology

Reprints in this Set

Marine Animals & Plants

Marine Microbes & Metagenomes